Methods for prediction and early detection of diabetes
US12313634B2 · kind B2 · utility
Assignees
Inventors
Key dates
| Filing date | Nov 20, 2018 |
| Grant date | May 27, 2025 |
| Priority date | — |
| Expiry date | Apr 7, 2042 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2800/085
- WIPO fieldMeasurement
- WIPO sectorInstruments
Abstract
An in vitro method for assessing whether a subject is at risk to develop or is suffering from fatty liver disease comprising: (a) assaying a sample from said subject to determine a concentration of at least one fatty liver biomarker from Group E; (b) assaying a sample from said subject to determine a concentration of at least one fatty liver biomarker from Group F; and (c) determining that the subject is suffering from or is at an increased risk of developing fatty liver disease, if said sample contains an increased combination biomarker value of the at least one fatty liver biomarker from Group E and the at least one fatty liver biomarker from Group F, when compared to a control.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.